Advertisement

Topics

Vista Communications Company Profile

08:22 EDT 23rd September 2018 | BioPortfolio


News Articles [192 Associated News Articles listed on BioPortfolio]

Vista Outdoor Finalizes Sale of Bollé, Cébé and Serengeti Brands

FARMINGTON, Utah, Sept. 4, 2018 /PRNewswire/ -- Vista Outdoor Inc. ("Vista Outdoor") (NYSE: VSTO) announced today that it has completed the divestiture of the legal Read more...

Vista Gold Corp. Announces Mt Todd Met Testing Results with Significantly Improved Gold Recoveries

DENVER, Aug. 2, 2018 /PRNewswire/ -- Vista Gold Corp. (TSX & NYSE American: VGZ) ("Vista" or the "Company") today announced results of its ongoing grinding Read more...

Where to Live Now: Silicon Valley Gets a Hollywood Twist in Playa Vista

Featured on CNN Internationalfor its innovative design and as a dynamic new hub for tech companies, including Google, YouTube, IMAX, and Yahoo!, Playa Vista Read more...

Vista Outdoor Announces Strategic Business Transformation Plan

FARMINGTON, Utah, May 1, 2018/PRNewswire/ -- Vista Outdoor Inc. (NYSE: VSTO) today announced its strategic business transformation plan, designed to allow the Read more...

VA Finally Signs Off On $10B Cerner EHR Contract, Replacing VistA EHR

On Thursday evening, the Department of Veterans Affairs (VA) announced an agreement with Cerner for the VA to use off-the-shelf Cerner solutions, replacing the legacy VistA EHR. The migration to Cerne...

Barona Band Of Mission Indians Awards Flora Vista Elementary School $5,000 Barona Education ...

SAN DIEGO, Sept. 21, 2018 /PRNewswire/ -- The Barona Band of Mission Indians has awarded students and teachers at Flora Vista Elementary School a $5,000 Read more...

Sesen Bio to present its three-month Phase 3 VISTA Trial data at Global Congress

Sesen Bio, Inc., a late-stage clinical company developing fusion protein therapies for the treatment of cancer, today announced that the company will present its three-month Phase 3 VISTA Trial data d...

#jobs #lifescience Communications Manager

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Communications Manager .MA-Chelmsford, Are you a Communications Manager with ...

Drugs and Medications [0 Results]

None

PubMed Articles [37 Associated PubMed Articles listed on BioPortfolio]

VSIG-3 as a ligand of VISTA inhibits human T cell function.

B7 family members and their receptors play a central role in the regulation of T cell responses through T cell costimulation and coinhibition pathways that constitute very attractive targets for the d...

Management of Multiple Gingival Recessions with the VISTA Technique: An 18-Month Clinical Case Series.

The purpose of the present study was to evaluate the efficacy of the vestibular incision subperiosteal tunnel access (VISTA) technique with collagen membrane, bioactive glass, and platelet-rich fibrin...

High-Density Infiltration of V-domain Immunoglobulin Suppressor of T-cell Activation Up-regulated Immune Cells in Human Pancreatic Cancer.

V-domain immunoglobulin suppressor of T-cell activation (VISTA) is constitutively expressed in hematopoietic lineage and is highly up-regulated in tumor infiltrated myeloid cells and regulatory T cell...

Newborn Screening and Health Communications.

Simplified Submission Requirements for Authors of JACS Communications.

Clinical Trials [29 Associated Clinical Trials listed on BioPortfolio]

Patient Satisfaction After Root Coverage Using VISTA Technique Compared to MCAF Technique With PRF.

VISTA technique with PRF compared to MCAF technique with PRF to treat gingival recession

Evaluation of Esthetic Root Coverage Using Platelet-Rich Fibrin Versus Subepithelial Connective Tissue Graft With Vestibular Incision Subperiosteal Tunnel Access in Multiple Gingival Recessions

Patients with gingival recession, complain of excessive tooth length that affects their appearance during smiling or functioning. The main goal of plastic periodontal surgeries is to resto...

A Study of CA-170 (Oral PD-L1, PD-L2 and VISTA Checkpoint Antagonist) in Patients With Advanced Tumors and Lymphomas

CA-170 is a rationally designed and orally available, small molecule that directly targets the Programmed death-ligands 1 and 2 (PD-L1/PD-L2), and V-domain Ig suppressor of T cell activati...

Safety and Patient Satisfaction With GLASH VISTA™ (Bimatoprost 0.03%) in the Treatment of Eyelash Hypotrichosis in Japan

This is a post-marketing surveillance study in Japan that will evaluate the safety and patient satisfaction with GLASH VISTA™ (bimatoprost cutaneous solution 0.03%) in the treatment of h...

Evaluation of EEG With Respect to the Change of Depth of Anesthesia During General Anesthesia

The BIS Index, one of the VISTA Monitor output parameters, may be used as an aid in monitoring the effects of certain anesthetic agents;and its usage with certain anesthetic agents may be ...

Companies [461 Associated Companies listed on BioPortfolio]

Vista Partners LLC

Vista Partners LLC was founded in 2005 and has offices in California and Oregon. Vista is one of the fastest growing independently owned equity research and consulting firms in the United States. Vist...

Vista Communications

Vista Partners

With offices in California and Oregon, Vista Partners LLC is one of the fastest growing independently owned equity research and consulting firms in the United States. Vista Partners professional staff...

New Vista Behavioral Health

New Vista Behavioral Health’s mission is to provide innovative, client-centered, evidence-based, treatment solutions to create a healthy and productive new vista for recovery...

Vista Equity Partners

Vista Equity Partners, a U.S.-based investment firm with offices in Austin, San Francisco, Chicago, and Oakland with more than $31 billion in cumulative capital commitments, curre...

More Information about "Vista Communications" on BioPortfolio

We have published hundreds of Vista Communications news stories on BioPortfolio along with dozens of Vista Communications Clinical Trials and PubMed Articles about Vista Communications for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Vista Communications Companies in our database. You can also find out about relevant Vista Communications Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record